| Management target | Revenue 30.0% FY27 |
|---|
| Revenue growth | 29% YoY growth driven by 47% rise in Ayurveda products. |
|---|---|
| Margins | EBITDA margins stable at 41%; PAT margin at 28%. |
| Demand visibility | Strong; patient footfalls up 10% QoQ despite reducing government business. |
| Management confidence | Aggressive and visionary; focused on building a long-term wellness ecosystem. |
Growth
Revenue grew 29% YoY to ₹224 Cr; Ayurveda product sales jumped 47% while government business was slashed.
Outlook
Targeting ₹3,000 Cr revenue and ₹1,000 Cr PAT within 3-5 years with 7,000-10,000 beds.
Risks
One-time warrants valuation and capital gains (₹7.5 Cr) inflated other income. High dependence on celebrity-led TV advertising.
Last quarter's promises, checked
Delivered
- Guided 2,800-3,000 beds in 3-4 months → delivered 3,000 beds (= BEAT)
- Guided FY26 Revenue ₹801 Cr → delivered ₹801 Cr (= BEAT)
- Guided 50-50 Product/Service mix → delivered 52% products/48% services (= BEAT)
Partly delivered
- Guided 4x-5x PAT growth in 3-5 years → FY26 PAT ₹222 Cr up 177% (= PARTIAL)
Missed
- Guided 1-2 months for insurance/Ayushman implementation → not fully operational (= MISS)
Earnings Call Transcript filed with BSE, NSE: JSLL. Summary written with AI assistance from the document.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹508.25
- Market cap
- ₹6,318 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 26.7×Sector 50.4×
- Promoter holding
- 63.62%+0.00% QoQ
- FII holding
- 4.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare has launched two new Ayurvedic products, Acharya Ji's Amrit Tattava Vati and Acharya Ji's Oja Amrit Vati, in the domestic market.
Jeena Sikho Lifecare Capacity Expansion
Jeena Sikho Lifecare postponed its new Lucknow hospital's commercial operations to December 2026 from August. The delay stems from expanded work scope and adverse site weather.
Jeena Sikho Lifecare Business Update
Jeena Sikho Lifecare Limited received NABH accreditation for its Pune hospital, affirming its adherence to quality healthcare standards and operational excellence.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched two new Ayurvedic products, Jeevanodya Vati and Ojavardhan Vati. This expands the company's portfolio of healthcare and wellness offerings.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Limited informed shareholders about the web-link to access its 2025-26 Annual Report and 9th AGM Notice.